Support system for heart failure with ATTR-CM
Part of Brain & nervous system, Genetic & congenital, Heart & circulation, Hormones & metabolism clinical trials.
This trial tests an eHealth support system designed to help people with ATTR amyloidosis (a type of heart disease) who have had a recent heart failure episode. It aims to improve care and follow-up for people with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with heart failure
- You had a heart failure episode (decompensation) in the last year
- You have been diagnosed with ATTR-CM (hereditary or wild-type)
- You have someone to help care for you at home
- You are not already in another trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses heart scans to see how the drug acoramidis affects heart structure and function in people with a specific type of heart disease called ATTR cardiomyopathy. It may help doctors understand if the treatment is working.
This trial tests if a smartphone app or similar remote tools can help doctors catch early signs that heart failure is getting worse in people who have a defibrillator (ICD) or biventricular pacemaker (CRT) that sends data to the clinic. Participating helps researchers figure out if this type of check-in from home works better than standard care.
This study tests a mobile app to help people with heart failure take better care of themselves after leaving the hospital. It could help you manage your condition and avoid being readmitted.
This study tests a mobile health program (phone app and coaching) to help people with heart failure better manage their condition at home. It aims to improve self-care and reduce hospital visits.
This trial tests a smartphone-based program (HeartMed-HF) to see if it can help people with heart failure after a recent heart attack exercise more and feel better. If you join, you'll use a digital tool to guide your recovery.
This trial studies whether a structured exercise training program is safe and helpful for people with transthyretin (ATTR) cardiac amyloidosis. It may help improve fitness and daily functioning, and it may also compare groups for specific eligibility needs.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.